Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael H Cynamon

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Antimicrobial Agents and Chemotherapy|June 3, 2010
In vitro antituberculosis activities of ACH-702, a novel isothiazoloquinolone, against quinolone-susceptible and quinolone-resistant isolatesMichael J Pucci, Maria Ackerman, Jane A Thanassi, et al.
Scandinavian Journal of Infectious Diseases|April 6, 2004
Recurrent Mycobacterium xenopi infection in a patient with rheumatoid arthritis receiving etanerceptKyongwook Yim, Syed H Nazeer, Deanna Kiska, et al.
Infection and Immunity|June 24, 2003
The largest open reading frame (pks12) in the Mycobacterium tuberculosis genome is involved in pathogenesis and dimycocerosyl phthiocerol synthesisTatiana D Sirakova, Vinod S Dubey, Hwa-Jung Kim, et al.
Antimicrobial Agents and Chemotherapy|September 23, 2009
The antituberculosis drug pyrazinamide affects the course of cutaneous leishmaniasis in vivo and increases activation of macrophages and dendritic cellsSusana Mendez, Ryan Traslavina, Meleana Hinchman, et al.
The Journal of Antimicrobial Chemotherapy|February 20, 2004
Short-course treatment regimen to identify potential antituberculous agents in a murine model of tuberculosisCarolyn M Shoen, Michelle S DeStefano, Mary R Sklaney, et al.
Antimicrobial Agents and Chemotherapy|December 24, 2014
The efflux pump inhibitor timcodar improves the potency of antimycobacterial agentsTrudy H Grossman, Carolyn M Shoen, Steven M Jones, et al.
Microorganisms|February 25, 2022
Culture-Free Enumeration of <i>Mycobacterium tuberculosis</i> in Mouse Tissues Using the Molecular Bacterial Load Assay for Preclinical Drug DevelopmentDimitrios Evangelopoulos, Carolyn M Shoen, Isobella Honeyborne, et al.
Tuberculosis (Edinburgh, Scotland)|August 5, 2008
Inhibition of M. tuberculosis in vitro in monocytes and in mice by aminomethylene pyrazinamide analogsWoo Jin Chung, Andrei Kornilov, Benjamin H Brodsky, et al.
American Journal of Veterinary Research|October 26, 2011
Effects of opsonization of Rhodococcus equi on bacterial viability and phagocyte activationDominic R Dawson, Daryl V Nydam, Christopher T Price, et al.
Plos One|June 4, 2011
New classes of alanine racemase inhibitors identified by high-throughput screening show antimicrobial activity against Mycobacterium tuberculosisKaren G Anthony, Ulrich Strych, Kacheong R Yeung, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Antimicrobial Agents and Chemotherapy|June 3, 2010
In vitro antituberculosis activities of ACH-702, a novel isothiazoloquinolone, against quinolone-susceptible and quinolone-resistant isolatesMichael J Pucci, Maria Ackerman, Jane A Thanassi, et al.
Scandinavian Journal of Infectious Diseases|April 6, 2004
Recurrent Mycobacterium xenopi infection in a patient with rheumatoid arthritis receiving etanerceptKyongwook Yim, Syed H Nazeer, Deanna Kiska, et al.
Infection and Immunity|June 24, 2003
The largest open reading frame (pks12) in the Mycobacterium tuberculosis genome is involved in pathogenesis and dimycocerosyl phthiocerol synthesisTatiana D Sirakova, Vinod S Dubey, Hwa-Jung Kim, et al.
Antimicrobial Agents and Chemotherapy|September 23, 2009
The antituberculosis drug pyrazinamide affects the course of cutaneous leishmaniasis in vivo and increases activation of macrophages and dendritic cellsSusana Mendez, Ryan Traslavina, Meleana Hinchman, et al.
The Journal of Antimicrobial Chemotherapy|February 20, 2004
Short-course treatment regimen to identify potential antituberculous agents in a murine model of tuberculosisCarolyn M Shoen, Michelle S DeStefano, Mary R Sklaney, et al.
Antimicrobial Agents and Chemotherapy|December 24, 2014
The efflux pump inhibitor timcodar improves the potency of antimycobacterial agentsTrudy H Grossman, Carolyn M Shoen, Steven M Jones, et al.
Microorganisms|February 25, 2022
Culture-Free Enumeration of <i>Mycobacterium tuberculosis</i> in Mouse Tissues Using the Molecular Bacterial Load Assay for Preclinical Drug DevelopmentDimitrios Evangelopoulos, Carolyn M Shoen, Isobella Honeyborne, et al.
Tuberculosis (Edinburgh, Scotland)|August 5, 2008
Inhibition of M. tuberculosis in vitro in monocytes and in mice by aminomethylene pyrazinamide analogsWoo Jin Chung, Andrei Kornilov, Benjamin H Brodsky, et al.
American Journal of Veterinary Research|October 26, 2011
Effects of opsonization of Rhodococcus equi on bacterial viability and phagocyte activationDominic R Dawson, Daryl V Nydam, Christopher T Price, et al.
Plos One|June 4, 2011
New classes of alanine racemase inhibitors identified by high-throughput screening show antimicrobial activity against Mycobacterium tuberculosisKaren G Anthony, Ulrich Strych, Kacheong R Yeung, et al.
Pageof 3